A 34-year, gentleman named Adan (name changed), hailing from Ghana, South Africa adhering to Jehovahs beliefs, presented with ...

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...

OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has been awarded a ...

The ACG has released its first guidance for gastric premalignant conditions, such as atrophic gastritis, gastric intestinal ...

Circulating tumor DNA may be a prognostic biomarker for relapse and early recurrence detection in resected early-stage ...